Back to results
US 2014/0234966 A1Published application
Albumin formulation and use
AssigneeNovozymes Biopharma DK A/S
InventorsSandra Marie Merkel, Luke Dimasi, Collette Ann Sheahan, Philip Harvey Morton
Life of this patent
Estimating the term…
Abstract
The invention relates to a new formulation of albumin, a method for producing the albumin formulation and to uses of the albumin formulation, for example in cell culture such as mammalian cell culture and particularly in stem cell culture.
Claims21
A composition comprising albumin, a solvent, at least 200 mM cations, having a pH from about 5.0 to about 8.0 and wherein the composition comprises less than or equal to 5 mM octanoate.
(canceled)
Dependencies are inferred from the claim text.